Skip to main content
Article
Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial
Gastrointestinal Endoscopy (2019)
  • Reginald Bell, Institute of Esophageal and Reflux Surgery
  • John Lipham, University of Southern California
  • Brian Louie, Swedish Cancer Institute and Medical Center, Seattle, Washington, USA
  • Valerie Williams, St. Elizabeth's Healthcare
  • James Luketich, University of Pittsburgh
  • Michael Hill, Adirondack Surgical Group
  • William Richards, University of South Alabama
  • Christy Dunst, The Oregon Clinic, Portland, Oregon, USA
  • Dan Lister, Arkansas Heartburn Treatment Center
  • Lauren McDowell-Jacobs, Knox Community Hospital
  • Patrick R. Reardon, Houston Methodist Hospital
  • Karen Woods, Houston Methodist Hospital
  • Jon Gould, Medical College of Wisconsin
  • F. Paul Buckley, University of Texas at Austin
  • Shanu Kothari, Gundersen Health System
  • Leena Khaitan, University Hospitals, Cleveland, Cleveland, Ohio, USA
  • C. Daniel Smith, Esophageal Institute of Atlanta
  • Adrian Park, Anne Arundel Health System
  • Christopher Smith, Albany Surgical PC
  • Garth Jacobsen, University of California, San Diego
  • Ghulam Abbas, West Virginia University
  • Philip Katz, Cornell University
Publication Date
January 1, 2019
DOI
10.1016/j.gie.2018.07.007
Citation Information
Reginald Bell, John Lipham, Brian Louie, Valerie Williams, et al.. "Laparoscopic magnetic sphincter augmentation versus double-dose proton pump inhibitors for management of moderate-to-severe regurgitation in GERD: a randomized controlled trial" Gastrointestinal Endoscopy Vol. 89 Iss. 1 (2019) p. 14
Available at: http://works.bepress.com/brian-louie/21/